FDA Guidance: IND Submissions for Individualized ASOs (Nano-Rare Diseases)

by benforred | Jul 7, 2026

FDA IND Forms & Instructions (Form 1571, 1572, 3674, 3454, 3455)

by benforred | Jul 7, 2026

ICH M3(R2) Nonclinical Safety Studies Guidance for Human Clinical Trials

by benforred | Jul 7, 2026

ARRIVE 2.0 Guidelines & Reporting Checklist for In Vivo Studies 

by benforred | Jul 7, 2026

SMART IRB Reliance Agreement — Single IRB for Multi-Site Studies

by benforred | Jul 7, 2026